Most disease-associated genetic risk factors are regulatory. Here, we generated single-cell RNA-seq data of ~25,000 peripheral blood mononuclear cells from 45 donors to identify how genetic variants affect gene expression. We validated this approach by replicating previously published whole blood RNA-seq cis-expression quantitative trait loci effects (cis-eQTLs), but also identified new cell type-specific cis-eQTLs. These eQTLs give additional insight into the downstream consequences of genetic risk factors for immune-mediated diseases.
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Based on previous studies [3] [4] [5] , we hypothesize that the downstream expression effects of many disease risk-SNPs are cell type-specific. Previously, purified cell types 4, [6] [7] [8] or deconvolution methods 9, 10 have been used to identify cell type-specific eQTLs. However, these methods are either biased (cell-sorting), or are of limited use for less abundant cell types and dependent on accurate cell type quantification by previously defined marker genes (deconvolution). In contrast, single-cell RNA sequencing (scRNA-seq) could enable identification of cell type-specific eQTLs using an unbiased approach and can be used to investigate rare cell types 11 .
To determine the cell type-specific effects of genetic variation on gene expression, an eQTL analysis was performed in ~25,000 peripheral blood mononuclear cells (PBMCs) from 45 donors of the population cohort Lifelines Deep 12 . However, before executing a genome-wide eQTL analysis, we first validated our approach by focusing only on previously reported top cis-eQTLs detected in whole blood DeepSAGE 13 (which is also a 3'-end oriented RNA-sequencing strategy) or bulk RNA-seq 14 data. For this analysis, we treated our data as being bulk PBMC data, from now on referred to as "total PBMCs". We could significantly replicate 50 and 311 cis-eQTLs (of which 96.0% and 90.4% had the same allelic direction) for the DeepSAGE and RNA-seq study, respectively (Fig. 1a , Suppl. Table 1 ). The few disconcordant eQTLs between the datasets may be partly related to the slightly different composition of whole blood versus PBMCs, i.e. whole blood contains some extra cell types, including neutrophils and eosinophils. Altogether, this indicated that cis-eQTL mapping using scRNA-seq data yields reliable results.
We then performed a genome-wide cis-eQTL analysis on the total PBMCs and each of the major cell types we had identified (Suppl. Fig. 1a, 1b) . This was done by averaging the normalized gene expression of all cells per cell type per donor for the following cell types: CD4 + T cells, CD8 + T cells, natural killer (NK) cells, monocytes, B cells and dendritic cells (DC). In total, 379 unique top-eQTLs were detected (false discovery rate (FDR)≤0.05), of which 249 were found to be top-eQTLs in the total PBMCs (Table 1) . Of these 249, we could replicate 181 (90.1% concordance) in whole blood RNA-seq data 14 (Suppl. Table 2 ). Within the 130 remaining top-eQTLs, only 48 were not found significant in total PBMCs, but only in certain cell types (Suppl. Table 2 ). Several factors can explain why not all cis-eQTLs can be reproduced in the total PBMCs. First, unless using a very large sample size, the signal of an eQTL in a less abundant cell type may be diluted out in the total PBMCs. Along these lines, when using 2,116 whole blood RNA-seq samples from Zhernakova et al., we could replicate 29 out of 48 eQTLs (100% concordance). Leaving us with 19 cis-eQTLs that could not be found using such a large sample size of whole blood RNA-seq data. Secondly, in a common cell type, the eQTL may be masked by very high expression of this cis-regulated gene in a less abundant cell type lacking this eQTL. We observed this situation in CD4 + T-cells, where rs2272245 significantly affected the expression of the very lowly expressed TSPAN13 gene in cis. However, this effect was neither observed in any of the other cell types, nor in the total PBMCs, as in the total PBMCs the very high TSPAN13 expression of DCs masked the eQTL found in CD4 + T-cells (Fig. 1b) . Finally, eQTLs may show opposite allelic effects across different cell types. The small sample size of the less abundant cell types (Suppl. Fig. 1c ) did not allow for the identification of two significant opposite allelic effects. Despite this, in CD4 + T cells, the A allele of rs4804315 significantly decreased the expression of ZNF414 in cis (Nominal P-value = 6.09*10 -6 ), whereas in NK cells this same allele increased expression of ZNF414 (Nominal P-value = 0.0339) (Fig. 1b) . However, it cannot be excluded that specifically in NK cells, the effect of rs4804315 on ZNF414 expression is the result of a residual effect on ZNF414 expression of a second independent eQTL.
All the above-mentioned factors that may influence the reproducibility of cis-eQTLs in total PBMCs can be overcome using RNA-seq data of purified cell types. Indeed, 4 out of the 19 remaining cis-eQTLs (100% concordance) were reproduced in purified RNA-seq data of the Blueprint consortium (naïve CD4 + T cells and CD14 + monocytes) 15 or Kasela et al. (CD4 + and CD8 + T cells) 6 (Suppl. Table 3 ). Hence, only a small fraction (15 cis-eQTLs) of eQTLs were not identified before using RNA-seq data of either whole blood or purified cells (CD4 + and CD8 + T cells or monocytes). Even though some cis-eQTLs were only found significant in specific cell types, this does not imply they are cell type-specific; less abundant cell types may lack the statistical power required to detect these cis-eQTLs. Instead of tissue-by-tissue eQTL analysis, meta-analysis may increase the power to detect effects particularly in the less abundant cell types. However, commonly used meta-analyses for bulk RNA-seq, such as eQTL-BMA 16 or Meta-Tissue
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, are computationally too demanding for large scRNA-seq data or do not define the cell type in which the eQTL effect is present. 17, 18 The main advantage of scRNA-seq data for eQTL analysis is the flexibility by which any cell population of interest can be selected for analysis. In contrast, when using RNA-seq data of purified cell types, one cannot retrieve data from subcell types anymore. Moreover, the finer differences between subcell types may not always be recapitulated by different cell membrane markers, whereas they are on the gene expression level. To show the added value of performing an eQTL analysis on scRNA-seq data, we performed an analysis on the two identified subtypes of monocytes: classical (cMonocytes) and non-classical monocytes (ncMonocytes). When plotting the correlation coefficient of each top SNP-gene combination for the cMonocytes against the ncMonocytes, we revealed 4 clear examples in which we could pinpoint the eQTL effect specifically to the cMonocyte subset (Fig. 1c) . Each of these 4 eQTLs were already previously identified in RNA-seq data of purified CD14 + monocytes 15 , but by using the scRNA-seq data we could now identify these effects to be specific for the cMonocyte subset (Fig. 1d) .
The above examples clearly show the benefit of scRNA-seq data for eQTL analysis, but we expect scRNA-seq data to offer many other opportunities for selecting cells of interest for eQTL analysis. For example, one could use the intercellular variation within scRNA-seq data to group cells along the cell cycle, along a differentiation path or along a response to an environmental stimulus. By doing so, one may be able to define eQTLs that are amplified or abrogated depending on the cell cycle phase, differentiation status or environmental stimulus.
In the future, it is essential to improve the statistical power to detect eQTLs in scRNA-seq data. Especially the less abundant, less well-studied cell types are expected to benefit from this. One could do so by overcoming the zero-inflated expression that is inherent to scRNA-seq data by clever computational strategies that recover some of the expression 19 or by detecting eQTL effects on gene expression networks instead of individual genes 20 , thereby improving the reliability of the gene expression measurements. In addition, combining multiple scRNA-seq studies in one big meta-analysis is expected to exponentially increase the number of eQTLs that will be found.
In conclusion, this proof-of-concept study shows the feasibility of scRNA-seq data for eQTL analysis. The identified top-eQTLs replicated well with earlier reported whole blood RNA-seq data. Moreover, we extended the list of genes that are known to be under genetic regulation or specified the cell type in which the effect is most prominent. We expect that this study is just the start of many new opportunities to study how genetic variation is affecting single-cell gene expression levels. 
